2,917
edits
Natural therapeutics: Difference between revisions
→The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.
m (mv content unchanged) |
(→The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.) |
||
| Line 41: | Line 41: | ||
* [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter. | * [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter. | ||
* [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review | * [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review | ||
* [https://www.sciencedaily.com/releases/2019/02/190206115550.htm 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome'], a 2019 animal model study found downregulating CB1 receptors beneficial for the mice. | |||
=== The endocannabinoid receptors === | === The endocannabinoid receptors === | ||